Statistics for Protagonist Therapeutics (id:6456 PTGX)
Valuation metrics
Market cap
2.67B
Enterprise value
2.26B
Trailing P/E (ttm)
16.36
Forward P/E
-31.35
PEG ratio
-31.35
Price/Sales (ttm)
8.25
Price/Book (mrq)
5.02
Enterprise Value/Revenue
6.97
Enterprise Value/EBITDA
15.03
Overview
Shares outstanding
59.60M
Float
44.38M
Shares short
3.28M
% Held by insiders
0.01%
% Held by institutions
1.07%
Average volume (10 days)
1.18M
Average volume (90 days)
Price summary
52-Week low
17.63
52-Week high
48.89
52-Week change
60.54%
Beta
2.16
50-Day moving average
45.24
200-Day moving average
35.98
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
52.76%
Operating margin
-886.70%
Operational effectiveness
Return on assets
19.96%
Return on equity
40.97%
Income statement
Revenue (ttm)
5.30
Revenue per share (ttm)
5.30
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
150.07M
Net income to common (ttm)
170.85M
Diluted EPS (ttm)
2.74
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
468.72M
Total cash per share (mrq)
7.86
Total debt (mrq)
10.90M
Total Debt/Equity (mrq)
2.05
Current ratio (mrq)
1.07K%
Book value per share (mrq)
8.94
Cash flow
Cash flow statement
230.29M
Levered free cash flow (LFCF)
144.94M